Multimodal imaging deep learning model for predicting extraprostatic extension in prostate cancer using MpMRI and

Fei Yao1,2, Heng Lin1, Ying-Nan Xue1,2

  • 1Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, No. 1 of Xuefubei Road, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.

Abstract

Insights

A new deep learning model combining MRI and PET/CT scans accurately predicts extraprostatic extension in prostate cancer. This tool improves radiologist accuracy, aiding in personalized treatment decisions.

Area of Science:

  • Radiology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Accurate prediction of extraprostatic extension (EPE) is crucial for prostate cancer (PCa) treatment planning.
  • Current diagnostic methods have limitations in precisely determining EPE.
  • Multimodal imaging offers potential for improved diagnostic accuracy.

Purpose of the Study:

  • To develop a multimodal deep learning (DL) model integrating magnetic resonance imaging (mpMRI) and 18F-PSMA-PET/CT for EPE prediction in PCa.
  • To evaluate the DL model's effectiveness in enhancing radiologist diagnostic accuracy for EPE.
  • To assess the clinical net benefit of the developed DL model.

Main Methods:

  • Retrospective collection of clinical and imaging data from PCa patients who underwent radical prostatectomy.
  • Development of a multimodal DL model combining mpMRI and 18F-PSMA-PET/CT.
  • Comparison of the multimodal DL model's performance against single-modality models and radiologist assessments with and without model assistance.

Main Results:

  • The combined mpMRI + PET/CT multimodal DL model achieved an AUC of 0.82 in the primary institution and 0.81 in the external validation set.
  • The multimodal DL model demonstrated superior predictive accuracy compared to single-modality models.
  • Deep learning-assisted assessment significantly improved AUC and sensitivity (P < 0.05) compared to radiologists alone, with a modest specificity reduction.

Conclusions:

  • A multimodal deep learning model integrating mpMRI and 18F-PSMA-PET/CT shows strong predictive performance for EPE in prostate cancer.
  • The model effectively enhances radiologist accuracy in EPE assessment.
  • This AI tool shows potential for supporting individualized and precise therapeutic decision-making in prostate cancer management.